Author

Sudhir K. Ghandikota

Cincinnati Children's Hospital Medical CenterORCID 0000-0003-3996-992XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 2 Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:graph neural network· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Anil Goud JeggaiD· 3 shared Jaswanth YellaiD· 2 shared Harshavardhana H. EdigaiD· 1 shared Mihika SharmaiD· 1 shared Satish Kumar MadalaiD· 1 shared Tejaswini C. Cherukuri· 1 shared Yunguan WangiD· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenomics

Anil Goud JeggaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BioinformaticsIEEE International Conference on Bioinformatics and Biomedicine (BIBM)Peer-reviewedDec 6, 2022

GraMDTA: Multimodal Graph Neural Networks for Predicting Drug-Target Associations

Jaswanth Yella, Sudhir K. Ghandikota, Anil Goud Jegga

GraMDTA predicts drug-target associations using multimodal graph neural networks combining structural and knowledge graph representations.

6 citations

graph neural networkmachine learning (classical)

𝕏 PostBluesky

GenomicsPatternsPeer-reviewedApr 5, 2021

Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19

Sudhir K. Ghandikota, Mihika Sharma, Anil Goud Jegga

The paper performs secondary transcriptomic analysis of SARS-CoV-2 infection models to identify conserved differentially expressed genes and their associations with COVID-19-related traits and pathways.

9 citations

humanbulk RNA-seq

𝕏 PostBluesky

GenomicsTherapeutic Advances in Respiratory DiseasePeer-reviewedJan 1, 2020

Pan-transcriptome-based Candidate Therapeutic Discovery for Idiopathic Pulmonary Fibrosis

Yunguan Wang, Jaswanth Yella, Sudhir K. Ghandikota…·Anil Goud Jegga

This study identifies 77 potential therapeutics for IPF by analyzing gene expression and drug-perturbagen connectivity, including FDA-approved drugs and clinical trial compounds.

14 citations

humanbulk RNA-seq

𝕏 PostBluesky